Managing robotics in the generic pharmaceutical arena
نویسنده
چکیده
Robotics was introduced by Danbury Pharmacal, Inc. in 1987 in order to improve laboratory throughput for several new products. The author uses Danbury Pharmacal's experience to give an overview of various issues, such as acceptance by senior management and chemists, political confrontation, validation and product throughput.
منابع مشابه
The Availability and Affordability of Cardiovascular Medicines for secondary prevention in Tehran Province
Abstract Abstract Background: Availability and affordability of medicines are crucial to achieving success in prevention programs, particularly in developing countries. Objective: The aim of this study was to determine the availability and affordability of cardiovascular medicines for secondary prevention in Tehran province of Iran. Methods: A cross-sectional survey was conducted in Tehran pro...
متن کاملNew Product Development in the Pharmaceutical Industry: Evidence from Iran
In today’s competitive world, there are several strategies to deal with the fast changing environment, among which New product development (NPD) is a common strategy. However, almost half of the resources that companies devote to NPD are spent on products that may fail. This issue is particularly highlighted in the pharmaceutical industry mainly because of a long development-time, low success r...
متن کاملExpediting the formulation development process with the aid of automated dissolution in analytical research and development
The development of drugs in the generic pharmaceutical industry is a highly competitive arena of companies vying for few drug products that are coming off patent. Companies that have been successful in this arena are those that have met or surpassed the critical timeline associated with trial formulation development, analytical method development, and submission batch manufacturing and testing....
متن کاملEfficacy of Generic Granisetron vs Kytril® for PONV in Major Gynecological Operations: A Randomized, Double-blind Clinical Trial
Background Granisetron is a first-generation 5-HT3-receptor antagonist that has shown efficacy in preventing postoperative nausea and vomiting (PONV). In this randomized double-blind parallel-group clinical trial, we assessed the efficacy of generic granisetron versus Kytril®, in the prevention of PONV in patients undergoing general anesthesia for gynaecological surgeries. Method One hundred an...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- The Journal of Automatic Chemistry
دوره 14 شماره
صفحات -
تاریخ انتشار 1992